Recent Annual Filings for BIO.B
Fiscal Year |
Assets |
Revenues |
Costs & Expenses |
Comprehensive Income |
Cash Flow - Operating |
Cash Flow - Financing |
Total Net Cash Flow |
2023 |
$12,299,070,000 |
$2,671,300,000 |
$3,521,404,000 |
$-506,540,000 |
$374,943,000 |
$-425,647,000 |
$-30,496,000 |
2022 |
$13,501,666,000 |
$2,802,200,000 |
$7,506,473,000 |
$-3,918,804,000 |
$194,447,000 |
$973,576,000 |
$-39,570,000 |
2021 |
$17,775,795,000 |
$2,922,500,000 |
$-2,515,649,000 |
$3,787,893,000 |
$656,521,000 |
$-55,429,000 |
$-195,982,000 |
2020 |
$12,972,618,000 |
$2,545,600,000 |
$-2,362,038,000 |
$4,176,071,000 |
$575,328,000 |
$-523,041,000 |
$4,464,000 |
2019 |
$8,008,859,000 |
$2,311,700,000 |
$50,619,000 |
$1,718,285,000 |
$457,897,000 |
$-22,758,000 |
$228,487,000 |
2018 |
$5,611,068,000 |
$2,289,400,000 |
$1,776,741,000 |
$259,119,000 |
$285,494,000 |
$-48,680,000 |
$49,181,000 |
2017 |
$4,273,012,000 |
$2,160,153,000 |
$2,062,348,000 |
$443,277,000 |
$103,885,000 |
$341,000 |
$-72,440,000 |
2015 |
$3,711,542,000 |
$2,019,441,000 |
$1,873,594,000 |
$276,286,000 |
$186,210,000 |
$8,581,000 |
$44,298,000 |